Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19
ACM Boon, TL Bricker, EJ Fritch, SR Leist… - Journal of …, 2024 - Am Soc Microbiol
We developed a novel class of peptidomimetic inhibitors targeting several host cell human
serine proteases, including transmembrane protease serine 2 (TMPRSS2), matriptase, and …
serine proteases, including transmembrane protease serine 2 (TMPRSS2), matriptase, and …